COVID-19 Information - as of 4/16/2021

Media Inquiries:

Yale New Haven Health COVID-19 Testing Site at Masonicare
The YNHH testing site at Masonicare in Wallingford is open for testing by appointment only. Please click here to schedule an appointment. You can download the testing FAQs here.

Please note: This is a testing site ONLY.

2021 Reopening Plan:

Following health and safety guidelines is critical to the well-being of our residents and patients. Some areas and communities at Masonicare are beginning to resume limited activities. To view a list by community, please click here.

Note: schedule is subject to change as needed in response to COVID status.


  • Visits are up to 30 minutes in duration
  • Maximum of two (2) visitors at a time per resident
  • Visitations are scheduled and the number of visitors limited to reduce the risk of exposure for our residents and staff
  • Visitors must be 16 years of age and older
  • No pets allowed at this time
  • Visitors without a scheduled appointment will not be allowed to visit
  • All visitors must be screened prior to the visit and must be free from all symptoms identified on the screening tool. Any symptoms will result in the appointment being rescheduled. Do not visit if you are sick or have had a recent COVID exposure.
  • Screening will occur in the Wilder Lounge, first floor
  • Visitors who have traveled outside of the state must observe any quarantine restrictions as directed by the State of Connecticut
  • Visits will occur in the Wilder Lounge area. Visitors are not allowed to travel into other areas of the building. Restrooms and the cafeteria are closed to visitors.
  • Face masks, preferably surgical masks, are required to be worn at all times and must cover the wearer’s nose and mouth. Residents will be assisted and encouraged to wear masks during the visit.
  • Masks must remain in place for the duration of the visits, therefore, eating and drinking is not permitted
  • Any items being brought into the facility must be left at the tables in the front foyer and not brought into the indoor visitation area. There can be no exchange of items during the in-person visit.
  • Staff will monitor compliance with mask-wearing and with maintaining social distancing of keeping 6 feet apart
  • Visitation areas will be disinfected and sanitized between each visit
  • Visitors that do not follow the outlined guidelines will receive verbal reminders; however, if non-compliance continues the visitor will be asked to end the visit and leave the facility immediately
  • We recommend you check the Masonicare website or call prior to your visit to verify that the visitation is still open and occurring as scheduled.


Earlier this week, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) issued a joint statement recommending a pause on the use of the Johnson & Johnson COVID-19 vaccine following six reported cases of a rare blood-clotting event. Although these reactions are rare, and no issues have been reported by the roughly 100,000 people who have received the J&J vaccine here in Connecticut, the Department of Public Health also recommended that COVID vaccine providers pause on the administration of the J&J vaccine for the time being while the FDA and CDC complete their review.

This announcement impacted a vaccine clinic at Masonicare at Mystic on Tuesday, where some of our employees were expecting to have access to the J&J vaccine.

I take this as a sign that the FDA, the CDC, and DPH all take vaccine safety very seriously. Even though reports of complications are extremely rare, they still want to await the results of the investigation before recommending further use of the J&J vaccine. I support that approach because it’s important that we build public trust in vaccines. Dr. Anthony Fauci, America’s leading infectious disease expert, said the review will likely take days or weeks, but probably not months.

At this time, we do not expect this to have any impact on Masonicare’s vaccination deadline of June 30. The Pfizer and Moderna vaccines are still the most common ones in use.


  • At Masonicare Health Center, one employee is out on precautionary quarantine due to community exposure.
  • GMPP reports one COVID-positive patient.


  • Masonicare Home Health & Hospice currently has one COVID-positive patient on service and three employees out.


  • One Chester Village resident is on quarantine due to exposure to a COVID-positive PDA (non-Masonicare).


Hope Ouelette, Manager of Education and Infection Prevention at Masonicare Health Center, is our guest on this week’s video. In December, when we began vaccinations for our residents and employee team members, Hope was asked to be the first Masonicare employee to receive the COVID-19 vaccine. She talks about the significance of that moment, both personally and professionally. And Dr. Ronald Schwartz, Masonicare Senior Director for Continuum Health Services, provides information about the increase in cases of what’s being called “the UK variant” of COVID-19, particularly amongst younger people, and stresses how critical it is for us all to continue to make careful decisions when it comes to our social activities. You can watch below.

4/14/2021: COVID-19 Update from Masonicare President & CEO, JP Venoit and Dr. Ronald Schwartz

Back to Top

Visit the COVID-19 Archives for previous updates